Skip to main content
Journal cover image

Preoperative CYP2D6 metabolism-dependent β-blocker use and mortality after coronary artery bypass grafting surgery.

Publication ,  Journal Article
Kertai, MD; Esper, SA; Akushevich, I; Voora, D; Ginsburg, GS; Stafford-Smith, M; Grichnik, K; Newman, MF; Fontes, ML; Smith, P; Podgoreanu, MV ...
Published in: J Thorac Cardiovasc Surg
April 2014

OBJECTIVE: Recently, the role of β-blockers (BBs) in reducing perioperative mortality has been challenged. The conflicting results might have resulted from the extent of BB metabolism by the cytochrome P-450 (CYP2D6) isoenzyme. The purpose of the present study was to assess the association between the preoperative use of BBs dependent on metabolism of the CYP2D6 isoenzyme with operative mortality after coronary artery bypass grafting surgery. METHODS: We performed a retrospective study of 5248 patients who had undergone coronary bypass grafting surgery from January 1, 2001 to November 30, 2009 at Duke University Medical Center. The cohorts were defined by the preoperative use of BBs and BB type (non-CYP2D6_BBs, CYP2D6_BBs, or no BBs). Operative mortality was analyzed using inverse probability-weighted estimators with propensity score adjustment. RESULTS: Of the 5248 patients, 14% received non-CYP2D6_BBs, 43%, CYP2D6_BBs, and 43%, no BBs. The incidence of operative mortality was 0.8%, 2.1%, and 3.7% in the non-CYP2D6_BB, CYP2D6_BB, and no BB groups, respectively. Multivariable inverse probability-weighted-adjusted analyses showed that non-CYP2D6_BBs were associated with a lower incidence of operative mortality (odds ratio, 0.33; 95% confidence interval, 0.13-0.83; P = .02) compared with no BB use and a trend toward lower operative mortality (odds ratio, 0.44; 95% confidence interval, 0.16-1.07; P = .06) compared with CYP2D6_BBs. No significant decrease occurred in the risk of operative mortality between the CYP2D6_BB and no BB groups (odds ratio, 0.85; 95% confidence interval, 0.54-1.34; P = .48). CONCLUSIONS: Among these patients, preoperative non-CYP2D6_BB use, but not CYP2D6_BB use, was associated with a decreased risk of operative mortality.

Duke Scholars

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

April 2014

Volume

147

Issue

4

Start / End Page

1368 / 1375.e3

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Respiratory System
  • Preoperative Care
  • Middle Aged
  • Male
  • Humans
  • Female
  • Cytochrome P-450 CYP2D6
  • Coronary Artery Bypass
  • Aged, 80 and over
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kertai, M. D., Esper, S. A., Akushevich, I., Voora, D., Ginsburg, G. S., Stafford-Smith, M., … Cardiothoracic Anesthesia Research Endeavors (CARE) Group. (2014). Preoperative CYP2D6 metabolism-dependent β-blocker use and mortality after coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg, 147(4), 1368-1375.e3. https://doi.org/10.1016/j.jtcvs.2013.09.067
Kertai, Miklos D., Stephen A. Esper, Igor Akushevich, Deepak Voora, Geoffrey S. Ginsburg, Mark Stafford-Smith, Katherine Grichnik, et al. “Preoperative CYP2D6 metabolism-dependent β-blocker use and mortality after coronary artery bypass grafting surgery.J Thorac Cardiovasc Surg 147, no. 4 (April 2014): 1368-1375.e3. https://doi.org/10.1016/j.jtcvs.2013.09.067.
Kertai MD, Esper SA, Akushevich I, Voora D, Ginsburg GS, Stafford-Smith M, et al. Preoperative CYP2D6 metabolism-dependent β-blocker use and mortality after coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg. 2014 Apr;147(4):1368-1375.e3.
Kertai, Miklos D., et al. “Preoperative CYP2D6 metabolism-dependent β-blocker use and mortality after coronary artery bypass grafting surgery.J Thorac Cardiovasc Surg, vol. 147, no. 4, Apr. 2014, pp. 1368-1375.e3. Pubmed, doi:10.1016/j.jtcvs.2013.09.067.
Kertai MD, Esper SA, Akushevich I, Voora D, Ginsburg GS, Stafford-Smith M, Grichnik K, Newman MF, Fontes ML, Smith P, Podgoreanu MV, Mathew JP, Cardiothoracic Anesthesia Research Endeavors (CARE) Group. Preoperative CYP2D6 metabolism-dependent β-blocker use and mortality after coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg. 2014 Apr;147(4):1368-1375.e3.
Journal cover image

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

April 2014

Volume

147

Issue

4

Start / End Page

1368 / 1375.e3

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Respiratory System
  • Preoperative Care
  • Middle Aged
  • Male
  • Humans
  • Female
  • Cytochrome P-450 CYP2D6
  • Coronary Artery Bypass
  • Aged, 80 and over